Cargando…

The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer

The high mortality rate for pancreatic cancer (PC) is due to the lack of specific symptoms at early tumor stages and a high biological aggressiveness. Reliable biomarkers and new therapeutic targets would help to improve outlook in PC. In this study, we analyzed the expression of GNMT in a panel of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinzman, Zachary, Schmidt, Connor, Sliwinski, Marek K., Goonesekere, Nalin C. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998508/ https://www.ncbi.nlm.nih.gov/pubmed/33802396 http://dx.doi.org/10.3390/ph14030209

Ejemplares similares

A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
por: Goonesekere, Nalin C. W., et al.
Publicado: (2014)

Evaluating the efficacy of a structure-derived amino acid substitution matrix in detecting protein homologs by BLAST and PSI-BLAST
por: Goonesekere, Nalin CW
Publicado: (2009)

Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis
por: Liu, Xue-qi, et al.
Publicado: (2020)

Dietary Methionine Restriction Reverses Liver Cancer Driving Metabotype in GNMT KO Mice
por: Hall, Madeline, et al.
Publicado: (2022)

TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency
por: Fernández-Álvarez, Sara, et al.
Publicado: (2014)

Mining functional subgraphs from cancer protein-protein interaction networks
por: Shen, Ru, et al.
Publicado: (2012)

miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
por: Fernández-Tussy, Pablo, et al.
Publicado: (2019)

Chemical Constituents with GNMT-Promoter-Enhancing and NRF2-Reduction Activities from Taiwan Agarwood Excoecaria formosana
por: Wu, Ho-Cheng, et al.
Publicado: (2020)

Differential expression of NPM, GSTA3, and GNMT in mouse liver following long-term in vivo irradiation by means of uranium tailings
por: Yi, Lan, et al.
Publicado: (2018)

Downregulation of Methionine Cycle Genes MAT1A and GNMT Enriches Protein-Associated Translation Process and Worsens Hepatocellular Carcinoma Prognosis
por: Chen, Po-Ming, et al.
Publicado: (2022)

Utilizing proteomic approach to identify nuclear translocation related serine kinase phosphorylation site of GNMT as downstream effector for benzo[a]pyrene
por: Yang, Ming-Hui, et al.
Publicado: (2019)

Genome Report—A Genome Sequence Analysis of the RB51 Strain of Brucella abortus in the Context of Its Vaccine Properties
por: Bricker, Betsy, et al.
Publicado: (2020)

AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage
por: Fang, Cheng-Chieh, et al.
Publicado: (2018)

ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production
por: Kishi, Shingo, et al.
Publicado: (2023)

Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma
por: Kant, Rajni, et al.
Publicado: (2019)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

DDX49 is a novel biomarker and therapeutic target for lung cancer metastases
por: Lian, Xiaojuan, et al.
Publicado: (2019)

A rare case of superior approach for fluoroless atrial flutter ablation in a patient with dextrocardia, situs inversus, and interruption of the inferior vena cava
por: Soneji, Nisha, et al.
Publicado: (2022)

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
por: Wrona, Ewa, et al.
Publicado: (2021)

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer
por: He, Li-Hong, et al.
Publicado: (2023)

LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma
por: Xu, Rong, et al.
Publicado: (2022)

Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma
por: Chen, Shihong, et al.
Publicado: (2022)

Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
por: Aslanoglou, Despoina, et al.
Publicado: (2022)

Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma
por: Alhasan, Sari F, et al.
Publicado: (2016)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma
por: Namsolleck, Pawel, et al.
Publicado: (2023)

HUS1 as a Potential Therapeutic Target in Urothelial Cancer
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

Total pancreatectomy with islet autotransplantation reduces opioid use and improves nutritional support in children with debilitating pancreatitis
por: Heinzman, Christie, et al.
Publicado: (2023)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

A Case of Pancreatic Cyst
por: Martin, A. Angus
Publicado: (1893)

A Case of Pancreatic Cyst
por: Johnson, William D.
Publicado: (1907)

Autophagy as a therapeutic target in pancreatic cancer
por: Piffoux, Max, et al.
Publicado: (2020)

Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma
por: Deng, Yanyao, et al.
Publicado: (2022)

Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
por: Luan, Hong, et al.
Publicado: (2023)

A Fragmenting Hybrid Approach for Targeted Delivery of Multiple Therapeutic Agents to the Malaria Parasite
por: Mahajan, Sumit S, et al.
Publicado: (2011)

Biomarkers and Targeted Therapy in Pancreatic Cancer
por: Karandish, Fataneh, et al.
Publicado: (2016)

A Multi‐target Small Molecule for Targeted Transcriptional Activation of Therapeutically Significant Nervous System Genes
por: Wei, Yulei, et al.
Publicado: (2016)

The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
por: Abdul Rahman, Rozana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p73ullo7fn4jqjeu45l1lkulkl